# EDGAR Filing Document

**Accession Number:** 0001635977
**File Stem:** 0001752724-23-039745
**Filing Date:** 2023-2
**Character Count:** 111015
**Document Hash:** 0bd3db9937e0db760cad111754320157
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-23-039745.hdr.sgml**: 20230224

**ACCESSION NUMBER**: 0001752724-23-039745

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230224

**DATE AS OF CHANGE**: 20230224

**PERIOD START**: 20230930

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tekla World Healthcare Fund
- **CENTRAL INDEX KEY:** 0001635977
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** MA

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23037
- **FILM NUMBER:** 23665982

**BUSINESS ADDRESS:**
- **STREET 1:** 100 FEDERAL STREET
- **STREET 2:** 19TH FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02110
- **BUSINESS PHONE:** (617) 772-8515

**MAIL ADDRESS:**
- **STREET 1:** 100 FEDERAL STREET
- **STREET 2:** 19TH FLOOR
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02110

## Nport-Ex

**<u>Tekla World Healthcare Fund</u>**

**SCHEDULE OF INVESTMENTS**

*December 31, 2022*

*(Unaudited)*

---

| | | |
|:---|:---|:---|
| **PRINCIPAL<br> AMOUNT** | **NON-CONVERTIBLE NOTES - 16.2% of Net Assets** | **VALUE** |
|  | &nbsp;&nbsp;&nbsp;**France – 0.5%** |  |
| $2600000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sanofi, 3.63% due 06/19/28 | $2487731 |
|  | &nbsp;&nbsp;&nbsp;**Ireland – 0.4%** |  |
| 516000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Endo Dac/Endo Finance LLC/Endo Finco, Inc., 9.50% due 07/31/27 <sup>(a)</sup> | 72240 |
| 789000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Endo Dac/Endo Finance LLC/Endo Finco, Inc., 6.00% due 06/30/28 <sup>(a)</sup> | 41422 |
| 997000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mallinckrodt International Finance S.A., 10.00% due 06/15/29 <sup>(a)</sup> | 535878 |
| 1500000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shire Acquisitions Investments Ireland DAC, 3.20% due 09/23/26 | 1408967 |
|  |  | 2058507 |
|  | &nbsp;&nbsp;&nbsp;**United Kingdom – 1.0%** |  |
| 5000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AstraZeneca plc, 3.38% due 11/16/25 | 4829476 |
|  | &nbsp;&nbsp;&nbsp;**United States – 14.3%** |  |
| 5652000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Abbott Laboratories, 4.75% due 11/30/36 | 5624317 |
| 3200000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AbbVie, Inc., 4.50% due 05/14/35 | 2972794 |
| 1705000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AbbVie, Inc., 4.45% due 05/14/46 | 1474617 |
| 2000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amgen, Inc., 3.63% due 05/22/24 | 1961211 |
| 1555000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Amgen, Inc., 2.00% due 01/15/32 | 1217338 |
| 831000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Baxalta, Inc., 4.00% due 06/23/25 | 809467 |
| 328000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Becton, Dickinson and Co., 3.73% due 12/15/24 | 319769 |
| 1400000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Bristol-Myers Squibb Co., 3.40% due 07/26/29 | 1301046 |
| 2785000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cigna Corp., 3.50% due 06/15/24 | 2724301 |
| 3200000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Cigna Corp., 2.38% due 03/15/31 | 2627271 |
| 2448000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CVS Health Corp., 1.88% due 02/28/31 | 1927570 |
| 985000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DH Europe Finance II Sarl, 3.25% due 11/15/39 | 791956 |
| 3200000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Elevance Health, Inc., 2.55% due 03/15/31 | 2690551 |
| 4000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;EMD Finance LLC, 3.25% due 03/19/25 <sup>(a)</sup> | 3835988 |
| 1400000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GlaxoSmithKline Capital plc, 3.00% due 06/01/24 | 1362405 |
| 1000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;GlaxoSmithKline Capital plc, 3.38% due 06/01/29 | 924032 |
| 1250000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HCA, Inc., 5.38% due 02/01/25 | 1249433 |
| 600000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;HCA, Inc., 5.25% due 04/15/25 | 596944 |
| 710000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IQVIA, Inc., 5.00% due 05/15/27 <sup>(a)</sup> | 676843 |
| 4300000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Johnson & Johnson, 2.45% due 03/01/26 | 4045117 |
| 1400000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Johnson & Johnson, 2.90% due 01/15/28 | 1306742 |
| 1400000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Laboratory Corporation of America Holdings, 3.60% due 02/01/25 | 1355946 |
| 1675000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Medtronic, Inc., 4.38% due 03/15/35 | 1589269 |
| 1400000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Merck & Co., Inc., 2.80% due 05/18/23 | 1389545 |
| 1463000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Merck & Co., Inc., 2.75% due 02/10/25 | 1403112 |
| 2115000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Novartis Capital Corp., 3.40% due 05/06/24 | 2072758 |
| 193000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Par Pharmaceutical, Inc., 7.50% due 04/01/27 <sup>(a)</sup> | 146675 |
| 5300000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pfizer, Inc., 3.45% due 03/15/29 | 4994091 |
| 1800000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pfizer, Inc., 4.00% due 12/15/36 | 1649058 |
| 1750000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior Housing Properties Trust, 4.75% due 05/01/24 | 1478750 |
| 2300000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Syneos Health, Inc., 3.63% due 01/15/29 <sup>(a)</sup> | 1850350 |
| 2560000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UnitedHealth Group, Inc., 3.88% due 12/15/28 | 2446272 |
| 6060000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UnitedHealth Group, Inc., 4.20% due 05/15/32 | 5769149 |

---

The accompanying notes are an integral part of this Schedule of Investments.

**<u>Tekla World Healthcare Fund</u>**

**SCHEDULE OF INVESTMENTS**

*December 31, 2022*

*(Unaudited, continued)*

---

| | | |
|:---|:---|:---|
| **PRINCIPAL<br> AMOUNT** | ***United States – continued*** | **VALUE** |
| $5000000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Zimmer Biomet Holdings, Inc., 4.25% due 08/15/35 | $4157475 |
|  |  | 70742162 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL NON-CONVERTIBLE NOTES**<br> (Cost $88,325,643)**  | 80117876 |

---

---

| | | |
|:---|:---|:---|
| **SHARES** | **CONVERTIBLE PREFERREDS (Restricted)** <sup>(b)(c)</sup> - 1.8% of Net Assets** | |
|  | &nbsp;&nbsp;&nbsp;**France – 0.2%** |  |
| 337442 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dynacure Series C | 1049328 |
|  | &nbsp;&nbsp;&nbsp;**Ireland – 0.4%** |  |
| 194134 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Priothera Ltd. Series A, 6.00% | 2078107 |
|  | &nbsp;&nbsp;&nbsp;**Switzerland – 0.4%** |  |
| 151333 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Oculis SA Series B2, 6.00% | 1610183 |
| 41109 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Oculis SA Series C, 6.00% | 437400 |
|  |  | 2047583 |
|  | &nbsp;&nbsp;&nbsp;**United States – 0.8%** |  |
| 290187 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Aristea Therapeutics, Inc. Series B, 8.00% | 1600004 |
| 424079 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Endeavor Biomedicines, Inc. Series B, 8.00% | 1999999 |
| 101839 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;IO Light Holdings, Inc. Series A2 | 343706 |
|  |  | 3943709 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL CONVERTIBLE PREFERREDS**<br> (Cost $11,058,749)**  | 9118727 |
|  | **COMMON STOCKS - 101.4% of Net Assets** |  |
|  | &nbsp;&nbsp;&nbsp;**Australia – 1.5%** |  |
| 38719 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CSL Ltd. | 7585882 |
|  | &nbsp;&nbsp;&nbsp;**Canada – 0.0%** |  |
| 7378 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fusion Pharmaceuticals, Inc. <sup>(c)</sup> | 23241 |
| 3689 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fusion Pharmaceuticals, Inc. (Restricted) <sup>(b) (c)</sup> | 10458 |
|  |  | 33699 |
|  | &nbsp;&nbsp;&nbsp;**China – 0.2%** |  |
| 4114 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BeiGene Ltd. ADR <sup>(c)</sup> | 904833 |
| 38848 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;I-Mab ADR <sup>(c)</sup> | 162385 |
|  |  | 1067218 |
|  | &nbsp;&nbsp;&nbsp;**Denmark – 3.6%** |  |
| 81867 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MorphoSys AG ADR <sup>(c)</sup> | 293084 |
| 130523 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Novo Nordisk A/S ADR <sup>(d)</sup> | 17664983 |
|  |  | 17958067 |
|  | &nbsp;&nbsp;&nbsp;**France – 1.2%** |  |
| 123454 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Sanofi ADR | 5978877 |
|  | &nbsp;&nbsp;&nbsp;**Germany – 1.4%** |  |
| 10000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Affimed N.V. <sup>(c)</sup> | 12400 |

---

The accompanying notes are an integral part of this Schedule of Investments.

**<u>Tekla World Healthcare Fund</u>**

**SCHEDULE OF INVESTMENTS**

*December 31, 2022*

*(Unaudited, continued)*

---

| | | |
|:---|:---|:---|
| **SHARES** | &nbsp;&nbsp;&nbsp;**Germany – continued** | **VALUE** |
| 131684 | &nbsp;&nbsp;&nbsp;Bayer AG | $6811944 |
|  |  | 6824344 |
|  | ***Ireland – 0.4%*** |  |
| 6534 | &nbsp;&nbsp;&nbsp;ICON plc <sup>(c)</sup> | 1269230 |
| 15882 | &nbsp;&nbsp;&nbsp;Perrigo Co. plc | 541417 |
|  |  | 1810647 |
|  | ***Israel – 0.2%*** |  |
| 90281 | &nbsp;&nbsp;&nbsp;Teva Pharmaceutical Industries Ltd. ADR <sup>(c)</sup> | 823363 |
|  | ***Italy – 0.3%*** |  |
| 71190 | &nbsp;&nbsp;&nbsp;Stevanato Group SpA | 1279284 |
|  | ***Japan – 1.7%*** |  |
| 44419 | &nbsp;&nbsp;&nbsp;Astellas Pharma, Inc. | 679113 |
| 54075 | &nbsp;&nbsp;&nbsp;Daiichi Sankyo Co., Ltd. | 1751133 |
| 6830 | &nbsp;&nbsp;&nbsp;Eisai Co., Ltd. | 452974 |
| 9682 | &nbsp;&nbsp;&nbsp;Hoya Corp. | 937289 |
| 7436 | &nbsp;&nbsp;&nbsp;M3, Inc. | 202728 |
| 28940 | &nbsp;&nbsp;&nbsp;Olympus Corp. | 518644 |
| 11330 | &nbsp;&nbsp;&nbsp;Ono Pharmaceutical Co., Ltd. | 266157 |
| 20808 | &nbsp;&nbsp;&nbsp;Otsuka Holdings Co., Ltd. | 682554 |
| 7707 | &nbsp;&nbsp;&nbsp;Shionogi & Co., Ltd. | 386759 |
| 3715 | &nbsp;&nbsp;&nbsp;Sysmex Corp. | 226399 |
| 9600 | &nbsp;&nbsp;&nbsp;Takeda Pharmaceuticals Co., Ltd. | 300713 |
| 105073 | &nbsp;&nbsp;&nbsp;Takeda Pharmaceuticals Co., Ltd. ADR | 1639139 |
| 17288 | &nbsp;&nbsp;&nbsp;Terumo Corp. | 493454 |
|  |  | 8537056 |
|  | ***Netherlands – 1.0%*** |  |
| 8220 | &nbsp;&nbsp;&nbsp;argenx SE ADR <sup>(c) (d)</sup> | 3113983 |
| 109860 | &nbsp;&nbsp;&nbsp;Koninklijke Philips N.V. | 1646801 |
|  |  | 4760784 |
|  | ***Switzerland – 8.2%*** |  |
| 9053 | &nbsp;&nbsp;&nbsp;Lonza Group AG | 4436181 |
| 136225 | &nbsp;&nbsp;&nbsp;Novartis AG ADR | 12358332 |
| 603430 | &nbsp;&nbsp;&nbsp;Roche Holding AG ADR | 23624284 |
|  |  | 40418797 |
|  | ***United Kingdom – 4.3%*** |  |
| 242692 | &nbsp;&nbsp;&nbsp;AstraZeneca plc ADR <sup>(d)</sup> | 16454517 |
| 181710 | &nbsp;&nbsp;&nbsp;Smith & Nephew plc ADR | 4886182 |
|  |  | 21340699 |
|  | ***United States – 77.4%*** |  |
| 10451 | &nbsp;&nbsp;&nbsp;1Life Healthcare, Inc. <sup>(c)</sup> | 174636 |
| 183665 | &nbsp;&nbsp;&nbsp;Abbott Laboratories <sup>(d)</sup> | 20164580 |
| 107285 | &nbsp;&nbsp;&nbsp;AbbVie, Inc. <sup>(d)</sup> | 17338329 |
| 35969 | &nbsp;&nbsp;&nbsp;Acadia Healthcare Co., Inc. <sup>(c) (d)</sup> | 2960968 |
| 4325 | &nbsp;&nbsp;&nbsp;Alerislife, Inc. <sup>(c)</sup> | 2379 |
| 10374 | &nbsp;&nbsp;&nbsp;Align Technology, Inc. <sup>(c)</sup> | 2187877 |
| 90363 | &nbsp;&nbsp;&nbsp;Allscripts Healthcare Solutions, Inc. <sup>(c)</sup> | 1594003 |
| 28956 | &nbsp;&nbsp;&nbsp;Amgen, Inc. | 7605004 |

---

The accompanying notes are an integral part of this Schedule of Investments.

**<u>Tekla World Healthcare Fund</u>**

**SCHEDULE OF INVESTMENTS**

*December 31, 2022*

*(Unaudited, continued)*

---

| | | |
|:---|:---|:---|
| **SHARES** | **United States – continued** | **VALUE** |
| 282002 | Ardelyx, Inc. <sup>(c)</sup> | $803706 |
| 142388 | Avantor, Inc. <sup>(c)</sup> | 3002963 |
| 11307 | Biogen, Inc. <sup>(c) (d)</sup> | 3131134 |
| 13100 | Biohaven Ltd. <sup>(c) (e)</sup> | 181828 |
| 189256 | Boston Scientific Corp. <sup>(c) (d)</sup> | 8756875 |
| 147326 | Bristol-Myers Squibb Co. <sup>(d)</sup> | 10600106 |
| 36156 | Catalent, Inc. <sup>(c)</sup> | 1627382 |
| 10797 | Charles River Laboratories International, Inc. <sup>(c)</sup> | 2352666 |
| 40328 | Cigna Corp. <sup>(d)</sup> | 13362280 |
| 8700 | Community Health Systems, Inc. <sup>(c)</sup> | 37584 |
| 14900 | Community Healthcare Trust, Inc. | 533420 |
| 30958 | Danaher Corp. | 8216872 |
| 71367 | DexCom, Inc. <sup>(c) (d)</sup> | 8081599 |
| 63841 | Diversified Healthcare Trust REIT | 41292 |
| 33603 | Edwards Lifesciences Corp. <sup>(c)</sup> | 2507120 |
| 3800 | Elevance Health, Inc. | 1949286 |
| 69036 | Eli Lilly & Co. <sup>(d)</sup> | 25256130 |
| 161709 | Galera Therapeutics, Inc. <sup>(c)</sup> | 240946 |
| 63888 | Gilead Sciences, Inc. | 5484785 |
| 143229 | Global Medical REIT, Inc. | 1357811 |
| 41852 | GSK plc ADR | 1470679 |
| 53333 | Guardant Health, Inc. <sup>(c)</sup> | 1450658 |
| 22603 | HCA Healthcare, Inc. <sup>(d)</sup> | 5423816 |
| 149567 | Healthcare Realty Trust, Inc. | 2882156 |
| 12000 | HealthEquity, Inc. <sup>(c)</sup> | 739680 |
| 83601 | Healthpeak Properties, Inc. | 2095877 |
| 27790 | Horizon Therapeutics plc <sup>(c)</sup> | 3162502 |
| 21683 | Humana, Inc. <sup>(d)</sup> | 11105816 |
| 19168 | IDEXX Laboratories, Inc. <sup>(c) (d)</sup> | 7819777 |
| 35804 | Illumina, Inc. <sup>(c)(d)</sup> | 7239569 |
| 29795 | Intuitive Surgical, Inc. <sup>(c) (d)</sup> | 7906103 |
| 12104 | IQVIA Holdings, Inc. <sup>(c)</sup> | 2479989 |
| 122563 | Johnson & Johnson | 21650754 |
| 8389 | Laboratory Corporation of America Holdings <sup>(d)</sup> | 1975442 |
| 46903 | LTC Properties, Inc. | 1666464 |
| 35048 | Mallinckrodt plc <sup>(c)</sup> | 271622 |
| 11501 | McKesson Corp. | 4314255 |
| 145186 | Medical Properties Trust, Inc. | 1617372 |
| 85165 | Medtronic plc <sup>(d)</sup> | 6619024 |
| 149510 | Merck & Co., Inc. | 16588134 |
| 14416 | Moderna, Inc. <sup>(c)</sup> | 2589402 |
| 18716 | Molina Healthcare, Inc. <sup>(c) (d)</sup> | 6180398 |
| 4442 | National Health Investors, Inc. | 231961 |
| 71075 | Omega Healthcare Investors, Inc. | 1986546 |
| 403610 | Pfizer, Inc. <sup>(d)</sup> | 20680976 |
| 168741 | Physicians Realty Trust | 2441682 |
| 70097 | R1 RCM, Inc. <sup>(c)</sup> | 767562 |
| 4199 | Regeneron Pharmaceuticals, Inc. <sup>(c)</sup> | 3029536 |
| 20089 | ResMed, Inc. | 4181124 |
| 90781 | Sabra Health Care REIT, Inc. | 1128408 |
| 40329 | Stryker Corp. <sup>(d)</sup> | 9860037 |
| 23270 | Thermo Fisher Scientific, Inc. | 12814556 |

---

The accompanying notes are an integral part of this Schedule of Investments.

**<u>Tekla World Healthcare Fund</u>**

**SCHEDULE OF INVESTMENTS**

*December 31, 2022*

*(Unaudited, continued)*

---

| | | |
|:---|:---|:---|
| **SHARES** | ***United States – continued*** | **VALUE** |
| 65121 | UnitedHealth Group, Inc. <sup>(d)</sup> | $34525852 |
| 8183 | Universal Health Realty Income Trust | 390575 |
| 66681 | Ventas, Inc. | 3003979 |
| 16833 | Vertex Pharmaceuticals, Inc. <sup>(c) (d)</sup> | 4861034 |
| 41484 | Welltower, Inc. | 2719276 |
| 62792 | Zimmer Biomet Holdings, Inc. | 8005980 |
| 29308 | Zoetis, Inc. | 4295087 |
|  |  | 381727221 |
|  | **TOTAL COMMON STOCKS** <br> (Cost $486,092,561) | 500145938 |

---

---

| | | |
|:---|:---|:---|
| **PRINCIPAL AMOUNT** | **SHORT-TERM INVESTMENTS - 5.3% of Net Assets** |  |
| $25757000 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Repurchase Agreement, Fixed Income Clearing Corp., repurchase value $25,760,663, 1.28%, dated 12/30/22, due 01/03/23 (collateralized by U.S. Treasury Note 0.375% due 04/30/25, market value $26,272,159) | 25757000 |
| **SHARES** |  |  |
| 182280 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;State Street Institutional U.S. Government Money Market Fund, Institutional Class, 4.09% <sup>(f)</sup> | 182280 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL SHORT-TERM INVESTMENTS** <br> (Cost $25,939,280)**  | 25939280 |
|  | **TOTAL INVESTMENTS BEFORE MILESTONE INTEREST – 124.7%** |  |
|  | **(Cost $611,416,233)** | 615321821 |
| **INTERESTS** | **MILESTONE INTEREST (Restricted)** <sup>(b)(c)</sup> – 0.0% of Net Assets** |  |
|  | &nbsp;&nbsp;&nbsp;**Biotechnology – 0.0%** |  |
| 1 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Rainier Therapeutics Milestone Interest | 131663 |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**TOTAL MILESTONE INTEREST**<br> (Cost $143,115)**  | 131663 |

---

---

| | | |
|:---|:---|:---|
| **NUMBER OF<br> CONTRACTS<br> (100 SHARES<br> EACH)/ <br> NOTIONAL<br> AMOUNT ($)** | **OPTION CONTRACTS WRITTEN – (0.1)% of Net Assets** | **OPTION CONTRACTS WRITTEN – (0.1)% of Net Assets** |
|  | **Call Option Contracts Written – (0.1)%** |  |
| 268/(3082000) | Abbott Laboratories Feb 23 115 Call | (45024) |
| 305/(3355000) | Abbott Laboratories Jan 23 110 Call | (70150) |
| 53/(874500) | AbbVie, Inc. Jan 23 165 Call | (8374) |
| 35/(315000) | Acadia Healthcare Co., Inc. Jan 23 90 Call | (15050) |
| 12/(492000) | argenx SE Jan 23 410 Call | (3540) |
| 469/(3283000) | AstraZeneca plc Jan 23 70 Call | (23450) |
| 11/(330000) | Biogen, Inc. Feb 23 300 Call | (8030) |
| 11/(363000) | Biogen, Inc. Jan 23 330 Call | (1925) |
| 98/(460600) | Boston Scientific Corp. Jan 23 47 Call | (7350) |
| 212/(1590000) | Bristol-Myers Squibb Co. Feb 23 75 Call | (19716) |
| 216/(1782000) | Bristol-Myers Squibb Co. Jan 23 82.5 Call | (216) |
| 39/(1326000) | Cigna Corp. Jan 23 340 Call | (14625) |
| 68/(850000) | DexCom, Inc. Feb 23 125 Call | (23392) |
| 103/(1287500) | DexCom, Inc. Jan 23 125 Call | (10300) |

---

The accompanying notes are an integral part of this Schedule of Investments.

**<u>Tekla World Healthcare Fund</u>**

**SCHEDULE OF INVESTMENTS**

*December 31, 2022*

*(Unaudited, continued)*

---

| | | |
|:---|:---|:---|
| **NUMBER OF <br> CONTRACTS<br> (100 SHARES <br> EACH)/ <br> NOTIONAL <br> AMOUNT ($)** | **Call Option Contracts Written – continued** | **VALUE** |
| 68/(2652000) | Eli Lilly & Co. Feb 23 390 Call | $(41820) |
| 67/(2613000) | Eli Lilly & Co. Jan 23 390 Call | (11055) |
| 21/(546000) | HCA Healthcare, Inc. Feb 23 260 Call | (11151) |
| 24/(600000) | HCA Healthcare, Inc. Jan 23 250 Call | (4968) |
| 21/(1155000) | Humana, Inc. Feb 23 550 Call | (16170) |
| 10/(560000) | Humana, Inc. Jan 23 560 Call | (630) |
| 9/(387000) | IDEXX Laboratories, Inc. Jan 23 430 Call | (4500) |
| 35/(840000) | Illumina, Inc. Jan 23 240 Call | (2975) |
| 44/(1254000) | Intuitive Surgical, Inc. Feb 23 285 Call | (29172) |
| 48/(1368000) | Intuitive Surgical, Inc. Jan 23 285 Call | (8160) |
| 12/(300000) | Laboratory Corporation of America Holdings Jan 23 250 Call | (1560) |
| 101/(808000) | Medtronic plc Feb 23 80 Call | (19190) |
| 99/(792000) | Medtronic plc Jan 23 80 Call | (9405) |
| 18/(630000) | Molina Healthcare, Inc. Feb 23 350 Call | (14400) |
| 192/(2688000) | Novo Nordisk A/S Feb 23 140 Call | (65856) |
| 577/(3029250) | Pfizer, Inc. Jan 23 52.5 Call | (35774) |
| 38/(988000) | Stryker Corp. Feb 23 260 Call | (15580) |
| 44/(1056000) | Stryker Corp. Jan 23 240 Call | (35200) |
| 63/(3528000) | UnitedHealth Group, Inc. Feb 23 560 Call | (44730) |
| 63/(3465000) | UnitedHealth Group, Inc. Jan 23 550 Call | (29862) |
| 15/(465000) | Vertex Pharmaceuticals, Inc. Feb 23 310 Call | (6750) |
|  | **TOTAL OPTION CONTRACTS WRITTEN** <br> (Premiums received ($894297)) | (660050) |
|  | **TOTAL INVESTMENTS - 124.6%** <br> (Cost $610,665,051) | 614793434 |
|  | **OTHER LIABILITIES IN EXCESS OF ASSETS - (24.6)%** | (121373218) |
|  | **NET ASSETS - 100%** | $493420216 |

---

(a) Security exempt from registration under Rule 144A of the Securities Act of 1933, as amended. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers.

(b) Security fair valued using significant unobservable inputs. See Investment Valuation and Fair Value Measurements.

(c) Non-income producing security.

(d) A portion of security is pledged as collateral for call options written.

(e) All or a portion of this security is on loan as of December 31, 2022.

(f) This security represents the investment of cash collateral received for securities lending and is a registered investment company advised by State Street Global Advisors. The rate shown is the annualized seven-day yield as of December 31, 2022.

ADR American Depository Receipt

The accompanying notes are an integral part of this Schedule of Investments.

**<u>Tekla World Healthcare Fund</u>**

**SCHEDULE OF INVESTMENTS**

*December 31, 2022*

*(Unaudited, continued)*

**The following forward contracts were held as of December 31, 2022**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Description** | **Counterparty** | **Settlement <br> Date** | **Currency** | **Currency** | **Settlement<br> Value (in USD)** | **Current<br> Value** | **Unrealized<br> Gain/(Loss)** |
| **Contracts Sold:** |  |  |  |  |  |  |  |
| Australian Dollar | Goldman Sachs Bank | 01/31/23 | 4572304 | AUD | $3095052 | $3116422 | $(21370) |
| British Pound | Goldman Sachs Bank | 01/31/23 | 9440375 | GBP | 11430406 | 11421018 | 9388 |
| Danish Krone | Goldman Sachs Bank | 01/31/23 | 48474501 | DKK | 6965478 | 6992103 | (26625) |
| Euro | Goldman Sachs Bank | 01/31/23 | 11686116 | EUR | 12485681 | 12531825 | (46144) |
| Israeli Sheqel | Goldman Sachs Bank | 01/31/23 | 4457647 | ILS | 1272479 | 1269510 | 2969 |
| Japanese Yen | Goldman Sachs Bank | 01/31/23 | 523322125 | JPY | 3957516 | 4001113 | (43597) |
| Swiss Franc | Goldman Sachs Bank | 01/31/23 | 20140361 | CHF | 21725919 | 21844547 | (118628) |
|  |  |  |  |  |  | $61176538 | $(244007) |

---

The accompanying notes are an integral part of this Schedule of Investments.

**<u>Tekla World Healthcare Fund</u>**

**NOTES TO SCHEDULE OF INVESTMENTS**

*December 31, 2022*

*(Unaudited)*

***Investment Valuation***

Shares of publicly traded companies listed on national securities exchanges or trading in the over-the-counter market are typically valued at the last sale price, as of the close of trading, generally 4 p.m., Eastern Time. The Fund holds securities, currencies and other assets that are denominated in a foreign currency. The Fund will normally use the currency exchange rates as of 4:00 p.m. (Eastern Time) when valuing such assets. The Board of Trustees of the Fund (the Trustees) has established and approved fair valuation policies and procedures with respect to securities for which quoted prices may not be available or which do not reflect fair value. Convertible, corporate and government bonds are valued using a third-party pricing service. Convertible bonds are valued using this pricing service only on days when there is no sale reported. Puts and calls generally are valued at the close of regular trading on the securities or commodities exchange on which they are primarily traded. Options on securities generally are valued at their last sale price in the case of exchange traded options or, in the case of OTC-traded options, the average of the last sale price as obtained from two or more dealers unless there is only one dealer, in which case that dealer's price is used. Forward foreign currency contracts are valued on the basis of the value of the underlying currencies at the prevailing forward exchange rates. Restricted securities of companies that are publicly traded are typically valued based on the closing market quote on the valuation date adjusted for the impact of the restriction as determined in good faith by Tekla Capital Management LLC (the Adviser) also using fair valuation policies and procedures approved by the Trustees described below. Short-term investments with a maturity of 60 days or less are generally valued at amortized cost, which approximates fair value.

Convertible preferred shares, warrants or convertible note interests in private companies, milestone interests and other restricted securities, as well as shares of publicly traded companies for which market quotations are not readily available, such as stocks for which trading has been halted or for which there are no current day sales, or which do not reflect fair value, are typically valued in good faith, based upon the recommendations made by the Adviser pursuant to fair valuation policies and procedures approved by the Trustees.

The Adviser has a Valuation Sub-Committee comprised of senior management which reports to the Valuation Committee of the Board at least quarterly. Each fair value determination is based on a consideration of relevant factors, including both observable and unobservable inputs. Observable and unobservable inputs may include (i) the existence of any contractual restrictions on the disposition of securities; (ii) information obtained from the company, which may include an analysis of the company's financial statements products, intended markets or technologies; (iii) the price of the same or similar security negotiated at arm's length in an issuer's completed subsequent round of financing; (iv) the price and extent of public trading in similar securities of the issuer or of comparable companies; or (v) a probability and time value adjusted analysis of contractual terms. Where available and appropriate, multiple valuation methodologies are applied to confirm fair value. Significant unobservable inputs identified by the Adviser are often used in the fair value determination. A significant change in any of these inputs may result in a significant change in the fair value measurement. Due to the uncertainty inherent in the valuation process, such estimates of fair value may differ significantly from the values that would have been used had a ready market for the investments existed, and differences could be material. Additionally, changes in the market environment and other events that may occur over the life of the investments may cause the gains or losses ultimately realized on these investments to be different from the valuations used at the date of this schedule of investments.

***Federal Income Tax Cost***

At December 31, 2022, the cost of securities for Federal income tax purposes was $611,664,880. The net unrealized gain on securities held by the Fund was $3,128,554, including gross unrealized gain of $77,607,374 and gross unrealized loss of $74,478,820.

***Securities Lending***

The Fund may lend its securities to approved borrowers to earn additional income. The Fund receives cash collateral from the borrower and the initial collateral received by the fund is required to have a value of at least 102% of the current value of the loaned securities traded on U.S. exchanges, and a value of at least 105% for all other securities. The Fund will invest its cash collateral in State Street Institutional U.S. Government Money Market Fund (SAHXX), which is registered with the Securities and Exchange Commission (SEC) as an investment company. SAHXX invests substantially all of its assets in the State Street U.S. Government Money Market Portfolio. The Fund will receive the benefit of any gains and bear any losses generated by SAHXX with respect to the cash collateral.

**<u>Tekla World Healthcare Fund</u>**

**NOTES TO SCHEDULE OF INVESTMENTS**

*December 31, 2022*

*(Unaudited, continued)*

The Fund has the right to recall loaned securities on demand. If a borrower fails to return loaned securities when due, then the lending agent is responsible and indemnifies the Fund for the lent securities. The lending agent uses the collateral received from the borrower to purchase replacement securities of the same issue, type, class and series of the loaned securities. If the value of the collateral is less than the purchase cost of replacement securities, the lending agent is responsible for satisfying the shortfall but only to the extent that the shortfall is not due to any decrease in the value of SAHXX.

Although the risk of loss on securities lent is mitigated by receiving collateral from the borrower and through lending agent indemnification, the Fund could experience a delay in recovering securities or could experience a lower than expected return if the borrower fails to return the securities on a timely basis. The Fund receives compensation for lending its securities by retaining a portion of the return on the investment of the collateral and compensation from fees earned from borrowers of the securities. Securities lending income received by the Fund is net of fees retained by the securities lending agent. Net income received from SAHXX is a component of securities lending income as recorded by the Fund.

As of December 31, 2022, the Fund loaned securities valued at $172,112 and received $182,280 of cash collateral.

***Forward Contracts***

Forward contracts involve the purchase or sale of a specific quantity of a commodity, government security, foreign currency, or other asset at a specified price, with delivery and settlement at a specified future date. Because it is a completed contract, a purchase forward contract can be a cover for the sale of a futures contract. The Fund may enter into forward contracts for hedging purposes and non-hedging purposes (i.e., to increase returns). Forward contracts may be used by the Fund for hedging purposes to protect against uncertainty in the level of future foreign currency exchange rates, such as when the Fund anticipates purchasing or selling a foreign security. Forward contracts may also be used to attempt to protect the value of the Fund's existing holdings of foreign securities. Forward contracts may also be used for non-hedging purposes to pursue the Fund's investment objective. There is no requirement that the Fund hedge all or any portion of its exposure to foreign currency risks.

***Fair Value Measurements***

The Fund uses a three-tier hierarchy to prioritize the assumptions, referred to as inputs, used in valuation techniques to measure fair value. The three-tier hierarchy of inputs is summarized in the three broad levels. Level 1 includes quoted prices in active markets for identical investments. Level 2 includes prices determined using other significant observable inputs (including quoted prices for similar investments, interest rates, credit risk, etc.). The independent pricing vendor may value bank loans and debt securities at an evaluated bid price by employing methodologies that utilize actual market transactions, broker-supplied valuations, and/or other methodologies designed to identify the market value for such securities and such securities are considered Level 2 in the fair value hierarchy. Level 3 includes prices determined using significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments). These inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities.

For the period ended December 31, 2022, there were no transfers between levels.

The following is a summary of the levels used as of December 31, 2022 to value the Fund's investments.

**<u>Tekla World Healthcare Fund</u>**

**NOTES TO SCHEDULE OF INVESTMENTS**

*December 31, 2022*

*(Unaudited, continued)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| Assets and Liabilities at Value | Level 1 | Level 2 | Level 3 | Total |
| Non-convertible Notes |  |  |  |  |
| &nbsp;&nbsp;&nbsp;France | $- | $2487731 | $- | $2487731 |
| &nbsp;&nbsp;&nbsp;Ireland |  | 2058507 |  | 2058507 |
| &nbsp;&nbsp;&nbsp;United Kingdom |  | 4829476 |  | 4829476 |
| &nbsp;&nbsp;&nbsp;United States |  | 70742162 |  | 70742162 |
| Convertible Preferreds |  |  |  |  |
| &nbsp;&nbsp;&nbsp;France |  |  | 1049328 | 1049328 |
| &nbsp;&nbsp;&nbsp;Ireland |  |  | 2078107 | 2078107 |
| &nbsp;&nbsp;&nbsp;Switzerland |  |  | 2047583 | 2047583 |
| &nbsp;&nbsp;&nbsp;United States |  |  | 3943709 | 3943709 |
| Common Stocks |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Australia | 7585882 |  |  | 7585882 |
| &nbsp;&nbsp;&nbsp;Canada | 23241 | 10458 |  | 33699 |
| &nbsp;&nbsp;&nbsp;China | 1067218 |  |  | 1067218 |
| &nbsp;&nbsp;&nbsp;Denmark | 17958067 |  |  | 17958067 |
| &nbsp;&nbsp;&nbsp;France | 5978877 |  |  | 5978877 |
| &nbsp;&nbsp;&nbsp;Germany | 6824344 |  |  | 6824344 |
| &nbsp;&nbsp;&nbsp;Ireland | 1810647 |  |  | 1810647 |
| &nbsp;&nbsp;&nbsp;Israel | 823363 |  |  | 823363 |
| &nbsp;&nbsp;&nbsp;Italy | 1279284 |  |  | 1279284 |
| &nbsp;&nbsp;&nbsp;Japan | 8537056 |  |  | 8537056 |
| &nbsp;&nbsp;&nbsp;Netherlands | 4760784 |  |  | 4760784 |
| &nbsp;&nbsp;&nbsp;Switzerland | 40418797 |  |  | 40418797 |
| &nbsp;&nbsp;&nbsp;United Kingdom | 21340699 |  |  | 21340699 |
| &nbsp;&nbsp;&nbsp;United States | 381727221 |  |  | 381727221 |
| Short-term Investments | 182280 | 25757000 |  | 25939280 |
| Milestone Interest | - | - | 131663 | 131663 |
| Total | $500317760 | $105885334 | $9250390 | $615453484 |
| Assets |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Forward Currency Contracts | $- | $12357 | $- | $12357 |
| Liabilities |  |  |  |  |
| &nbsp;&nbsp;&nbsp;Forward Currency Contracts |  | (256364) |  | (256364) |
| &nbsp;&nbsp;&nbsp;Options Contracts Written | (660050) | - | - | (660050) |
| Total | $(660050) | $(244007) | $- | $(904057) |

---

The following is a reconciliation of Level 3 assets for which significant unobservable inputs were used to determine fair value.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| Investments in Securities | Balance as of <br> September 30,<br> 2022 | Net realized <br>gain (loss) and <br>change in unrealized appreciation <br>(depreciation) | Cost of <br>purchases <br>and <br>conversions | Proceeds <br>from sales <br>and <br>conversions | Net <br>transfers <br>into <br>(out of) <br>Level 3 | Balance as of December 31, 2022 |
| Convertible Preferreds |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;France | $960713 | $88483 | $132 | $— | $— | $1049328 |
| &nbsp;&nbsp;&nbsp;&nbsp;Ireland | 1902611 | 175496 |  |  |  | 2078107 |
| &nbsp;&nbsp;&nbsp;&nbsp;Switzerland | 2047583 |  |  |  |  | 2047583 |
| &nbsp;&nbsp;&nbsp;&nbsp;United States | 3943709 |  |  |  |  | 3943709 |
| Milestone Interest |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;United States | 138520 | (6857) |  |  |  | 131663 |
| Total | $8993136 | $257122 | $132 | $— | $— | $9250390 |

---

---

| | |
|:---|:---|
| Net change in unrealized appreciation (depreciation) from investments still held as of December 31, 2022 | $257122 |

---

**<u>Tekla World Healthcare Fund</u>**

**NOTES TO SCHEDULE OF INVESTMENTS**

*December 31, 2022*

*(Unaudited, continued)*

The following is a quantitative disclosure about significant unobservable inputs used in the determination of the fair value of Level 3 assets.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Fair Value at December 31,<br> 2022 | Valuation <br>Technique | Unobservable <br>Input | Range <br>(Weighted Average) |
| Convertible Preferreds | $9118727 | Transaction price | (a) | N/A |
| Milestone Interest | $131663 | Probability adjusted value | Probability of events Timing of events | 39.00%-99.00% (65.36%) <br> 1.75-12.75 (4.40) years |
|  | $9250390 |  |  |  |

---

(a) The valuation technique used as a basis to approximate fair value of these investments is based on a transaction price or subsequent
financing rounds.

***Private Companies and Other Restricted Securities***

The Fund may invest in private companies and other restricted securities if these securities would currently comprise 10% or less of Managed Assets. The value of these securities represented 2% of the Fund's Managed Assets at December 31, 2022.

At December 31, 2022, the Fund had commitments of $747,977 relating to additional investments in two private companies.

The following table details the acquisition date, cost, carrying value per unit, and value of the Fund's private companies and other restricted securities at December 31, 2022. The Fund on its own does not have the right to demand that such securities be registered.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Security (#)** | **Acquisition<br> Date** | **Cost** | **Carrying Value<br> per Unit** | **Value** |
| Aristea Therapeutics, Inc. Series B Cvt. Pfd | 07/27/21 | $1600004 | $5.51 | $1600004 |
| Dynacure Series C Cvt. Pfd | 04/21/20, 10/28/20 | 3142774 | 3.11 | 1049328 |
| Endeavor Biomedicines, Inc. Series B Cvt. Pfd | 01/21/22 | 2002482 | 4.72 | 1999999 |
| Fusion Pharmaceuticals, Inc. Common | 09/20/22 | 0 | 2.84 | 10458 |
| IO Light Holdings, Inc. Series A2 Cvt. Pfd | 04/30/20, 05/17/21, 09/15/21 | 336881 | 3.38 | 343706 |
| Oculis SA |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;Series B2 Cvt. Pfd | 01/16/19, 12/23/19 | 1274010 | 10.64 | 1610183 |
| &nbsp;&nbsp;&nbsp;&nbsp;Series C Cvt. Pfd | 04/07/21 | 437400 | 10.64 | 437400 |
| Priothera Ltd. Series A Cvt. Pfd | 10/07/20,10/19/21 | 2265198 | 10.70 | 2078107 |
| Rainier Therapeutics Milestone Interest | 09/28/21 | 143115 | 131663.00 | 131663 |
|  |  | $11201864 |  | $9260848 |

---

(#) See Schedule of Investments and corresponding footnotes for more information on each issuer. <br> † Interest received as part of a corporate action for a previously owned security.

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Tekla World Healthcare Fund

- **b. Investment Company Act file number:** 811-23037

- **c. CIK number of Registrant:** 0001635977

- **d. LEI of Registrant:** 549300XY2WS5AD8KC081

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 100 FEDERAL STREET,

  - **City:** BOSTON

  - **State:** MA

  - **Foreign country:** US

  - **Zip / Postal Code:** 02110

  - **Telephone number:** 617-772-8500

**Item A.2. Information about the Series.**

- **a. Name of Series:** Tekla World Healthcare Fund

- **c. LEI of Series:** 549300XY2WS5AD8KC081

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2023-09-30

- **b. Date as of which information is reported:** 2022-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $618099651.48

**Total Liabilities:** $125018359.89

**Net Assets:** $493081291.59

**Cash Not Reported:** $7.58

**Monthly Return Information**

| Class        | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID N/A | 7.72%                | 9.75%                | -1.07%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $996599.32               | $37635809.73                               |
| Month 2  | $-2549446.55             | $29954961.45                               |
| Month 3  | $-63793.21               | $-10358478.33                              |

### Schedule of Portfolio Investments

| Name                                                       | Title                                                       | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Charles River Laboratories International Inc               | Charles River Laboratories International Inc                | CUSIP: 159864107<br>LEI: 549300BSQ0R4UZ5KX287 | Long             | EC               | CORP              | US        |     10797 | NS      | $2352666.30   | 0.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Global Medical REIT Inc                                    | Global Medical REIT Inc                                     | CUSIP: 37954A204<br>LEI: 549300HFRIPQDYU3GU60 | Long             | EC               |  | US        |    143229 | NS      | $1357810.92   | 0.28%             |  |  |  | No            |                  1 | On Loan: No      |
| RAINIER THERAPEUTICS, INC.                                 | RAINIER THERAPEUTICS, INC.                                  | CUSIP: 000000000<br>LEI: N/A                  | Long             | EP               | CORP              | US        |      1921 | NS      | $131662.60    | 0.03%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Omega Healthcare Investors Inc                             | Omega Healthcare Investors Inc                              | CUSIP: 681936100<br>LEI: 549300OJ7ENK42CZ8E73 | Long             | EC               |  | US        |     71075 | NS      | $1986546.25   | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | INTUITIVE SURGICAL INC                                      | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -44 | NC      | $-29172.00    | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | UNITEDHEALTH GROUP INC                                      | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -63 | NC      | $-44730.00    | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | ABBOTT LABORATORIES                                         | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |      -268 | NC      | $-45024.00    | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| Welltower Inc                                              | Welltower Inc                                               | CUSIP: 95040Q104<br>LEI: T6IZ0MBEG5ACZDTR7D06 | Long             | EC               |  | US        |     41484 | NS      | $2719276.20   | 0.55%             |  |  |  | No            |                  1 | On Loan: No      |
| R1 RCM Inc                                                 | R1 RCM Inc                                                  | CUSIP: 77634L105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     70097 | NS      | $767562.15    | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Fixed Income Clearing Corp                                 | FIXED INC CLEARING CORP.REPO                                | CUSIP: 000000000<br>LEI: 549300H47WTHXPU08X20 | Long             | RA               | CORP              | US        |  25757000 | PA      | $25757000.00  | 5.22%             |  |  |  | No            |                  2 | On Loan: No      |
| HCA Inc                                                    | HCA Inc                                                     | CUSIP: 404119BQ1<br>LEI: L3CJ6J7LJ2DX62FTXD46 | Long             | DBT              | CORP              | US        |    600000 | PA      | $596944.45    | 0.12%             | 2025-04-15      | Fixed         | 5.25%                 | No            |                  2 | On Loan: No      |
| Vertex Pharmaceuticals Inc                                 | Vertex Pharmaceuticals Inc                                  | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     16833 | NS      | $4861033.74   | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | BRISTOL-MYERS SQUIBB CO                                     | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |      -212 | NC      | $-19716.00    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                                          | Johnson & Johnson                                           | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |    122563 | NS      | $21650753.95  | 4.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | LABORATORY CORP OF AMERICA HOL                              | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -12 | NC      | $-1560.00     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                                     | UnitedHealth Group Inc                                      | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |     65121 | NS      | $34525851.78  | 7.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                                                 | Pfizer Inc                                                  | CUSIP: 717081EC3<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | DBT              | CORP              | US        |   1800000 | PA      | $1649058.32   | 0.33%             | 2036-12-15      | Fixed         | 4.00%                 | No            |                  2 | On Loan: No      |
| AbbVie Inc                                                 | AbbVie Inc                                                  | CUSIP: 00287YAW9<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | DBT              | CORP              | US        |   1705000 | PA      | $1474617.48   | 0.30%             | 2046-05-14      | Fixed         | 4.45%                 | No            |                  2 | On Loan: No      |
| OCULIS SA SERIES B2 PREFERRED                              | OCULIS SA SERIES B2 PREFERRED                               | CUSIP: 000000000<br>LEI: N/A                  | Long             | EP               | CORP              | US        |    151333 | NS      | $1610183.12   | 0.33%             |  |  |  | Yes           |                  3 | On Loan: No      |
| DH EUROPE FINANCE II                                       | DH Europe Finance II Sarl                                   | CUSIP: 23291KAJ4<br>LEI: 222100KDGL314CKTZ511 | Long             | DBT              | CORP              | LU        |    985000 | PA      | $791955.91    | 0.16%             | 2039-11-15      | Fixed         | 3.25%                 | No            |                  2 | On Loan: No      |
| AbbVie Inc                                                 | AbbVie Inc                                                  | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |    107285 | NS      | $17338328.85  | 3.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | STRYKER CORP                                                | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -38 | NC      | $-15580.00    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Takeda Pharmaceutical Co Ltd                               | Takeda Pharmaceutical Co Ltd                                | CUSIP: 874060205<br>LEI: 549300ZLMVP4X0OGR454 | Long             | EC               | CORP              | JP        |    105073 | NS      | $1639138.80   | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Ventas Inc                                                 | Ventas Inc                                                  | CUSIP: 92276F100<br>LEI: ORQTRC074CWLT3DKHT41 | Long             | EC               |  | US        |     66681 | NS      | $3003979.05   | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                                            | AstraZeneca PLC                                             | CUSIP: 046353AL2<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | DBT              | CORP              | GB        |   5000000 | PA      | $4829476.10   | 0.98%             | 2025-11-16      | Fixed         | 3.38%                 | No            |                  2 | On Loan: No      |
| Olympus Corp                                               | Olympus Corp                                                | CUSIP: 000000000<br>LEI: 5299000Y52IFDI1I2A21 | Long             | EC               | CORP              | JP        |     28940 | NS      | $518644.32    | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc                               | Thermo Fisher Scientific Inc                                | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |     23270 | NS      | $12814556.30  | 2.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | ABBVIE INC                                                  | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -53 | NC      | $-8374.00     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | MEDTRONIC PLC                                               | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | IE        |       -99 | NC      | $-9405.00     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| AMGEN INC                                                  | Amgen Inc                                                   | CUSIP: 031162CZ1<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | DBT              | CORP              | US        |   1555000 | PA      | $1217338.08   | 0.25%             | 2032-01-15      | Fixed         | 2.00%                 | No            |                  2 | On Loan: No      |
| IO LIGHT HOLDINIGS, INC.                                   | IO LIGHT HOLDINIGS, INC.                                    | CUSIP: 000000000<br>LEI: N/A                  | Long             | EP               | CORP              | US        |    101839 | NS      | $343706.63    | 0.07%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Sanofi                                                     | Sanofi                                                      | CUSIP: 801060AD6<br>LEI: 549300E9PC51EN656011 | Long             | DBT              | CORP              | FR        |   2600000 | PA      | $2487731.12   | 0.50%             | 2028-06-19      | Fixed         | 3.63%                 | No            |                  2 | On Loan: No      |
| AbbVie Inc                                                 | AbbVie Inc                                                  | CUSIP: 00287YAR0<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | DBT              | CORP              | US        |   3200000 | PA      | $2972794.37   | 0.60%             | 2035-05-14      | Fixed         | 4.50%                 | No            |                  2 | On Loan: No      |
| ARISTEA THERAPEUTICS, INC.                                 | ARISTEA THERAPEUTICS, INC.                                  | CUSIP: 000000000<br>LEI: N/A                  | Long             | EP               | CORP              | US        |    290187 | NS      | $1600004.06   | 0.32%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Universal Health Realty Income Trust                       | Universal Health Realty Income Trust                        | CUSIP: 91359E105<br>LEI: 549300L4MWZL4IH6H172 | Long             | EC               |  | US        |      8183 | NS      | $390574.59    | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                                  | Amgen Inc                                                   | CUSIP: 031162BV1<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | DBT              | CORP              | US        |   2000000 | PA      | $1961210.78   | 0.40%             | 2024-05-22      | Fixed         | 3.63%                 | No            |                  2 | On Loan: No      |
| IQVIA Inc                                                  | IQVIA Inc                                                   | CUSIP: 46266TAA6<br>LEI: 549300PLWY28YB00C717 | Long             | DBT              | CORP              | US        |    710000 | PA      | $676843.00    | 0.14%             | 2027-05-15      | Fixed         | 5.00%                 | No            |                  2 | On Loan: No      |
| Horizon Therapeutics Plc                                   | Horizon Therapeutics Plc                                    | CUSIP: 000000000<br>LEI: 529900P0GSQ79OOZEV53 | Long             | EC               | CORP              | IE        |     27790 | NS      | $3162502.00   | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                                              | Medtronic PLC                                               | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |     85165 | NS      | $6619023.80   | 1.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | HUMANA INC                                                  | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -21 | NC      | $-16170.00    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| DIVERSIFIED HEALTHCARE T                                   | Diversified Healthcare Trust                                | CUSIP: 81721MAK5<br>LEI: N/A                  | Long             | DBT              |  | US        |   1750000 | PA      | $1478750.00   | 0.30%             | 2024-05-01      | Fixed         | 4.75%                 | No            |                  2 | On Loan: No      |
| Zoetis Inc                                                 | Zoetis Inc                                                  | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |     29308 | NS      | $4295087.40   | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| LABORATORY CORP OF AMER                                    | Laboratory Corp of America Holdings                         | CUSIP: 50540RAQ5<br>LEI: OZ7UA8IXAIFILY2VZH07 | Long             | DBT              | CORP              | US        |   1400000 | PA      | $1355945.54   | 0.27%             | 2025-02-01      | Fixed         | 3.60%                 | No            |                  2 | On Loan: No      |
| Boston Scientific Corp                                     | Boston Scientific Corp                                      | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    189256 | NS      | $8756875.12   | 1.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Zimmer Biomet Holdings Inc                                 | Zimmer Biomet Holdings Inc                                  | CUSIP: 98956P102<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | EC               | CORP              | US        |     62792 | NS      | $8005980.00   | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Otsuka Holdings Co Ltd                                     | Otsuka Holdings Co Ltd                                      | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | JP        |     20808 | NS      | $682554.40    | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| ResMed Inc                                                 | ResMed Inc                                                  | CUSIP: 761152107<br>LEI: 529900T3QE5253CCXF22 | Long             | EC               | CORP              | US        |     20089 | NS      | $4181123.57   | 0.85%             |  |  |  | No            |                  1 | On Loan: No      |
| Elevance Health Inc                                        | Elevance Health Inc                                         | CUSIP: 036752103<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | EC               | CORP              | US        |      3800 | NS      | $1949286.00   | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Goldman Sachs Bank USA                                     | PURCHASED USD / SOLD CHF                                    | CUSIP: 000000000<br>LEI: KD3XUN7C6T14HNAYLU02 | N/A              | DFE              |  | US        |         1 | NC      | $-118627.96   | -0.02%            |  |  |  | No            |                  2 | On Loan: No      |
| Biogen Inc                                                 | Biogen Inc                                                  | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     11307 | NS      | $3131134.44   | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| GSK PLC                                                    | GSK PLC                                                     | CUSIP: 37733W204<br>LEI: 5493000HZTVUYLO1D793 | Long             | EC               | CORP              | GB        |     41852 | NS      | $1470679.28   | 0.30%             |  |  |  | No            |                  1 | On Loan: No      |
| CVS HEALTH CORP                                            | CVS Health Corp                                             | CUSIP: 126650DQ0<br>LEI: 549300EJG376EN5NQE29 | Long             | DBT              | CORP              | US        |   2448000 | PA      | $1927569.84   | 0.39%             | 2031-02-28      | Fixed         | 1.88%                 | No            |                  2 | On Loan: No      |
| Options Clearing Corp.                                     | INTUITIVE SURGICAL INC                                      | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -48 | NC      | $-8160.00     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| FUSION PHARMACEUTICALS, INC.                               | FUSION PHARMACEUTICALS, INC.                                | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3689 | NS      | $10458.32     | 0.00%             |  |  |  | Yes           |                  2 | On Loan: No      |
| Daiichi Sankyo Co Ltd                                      | Daiichi Sankyo Co Ltd                                       | CUSIP: 000000000<br>LEI: 353800XGIU2IHQGC9504 | Long             | EC               | CORP              | JP        |     54075 | NS      | $1751133.42   | 0.36%             |  |  |  | No            |                  1 | On Loan: No      |
| ZIMMER BIOMET HOLDINGS                                     | Zimmer Biomet Holdings Inc                                  | CUSIP: 98956PAG7<br>LEI: 2P2YLDVPES3BXQ1FRB91 | Long             | DBT              | CORP              | US        |   5000000 | PA      | $4157474.85   | 0.84%             | 2035-08-15      | Fixed         | 4.25%                 | No            |                  2 | On Loan: No      |
| Physicians Realty Trust                                    | Physicians Realty Trust                                     | CUSIP: 71943U104<br>LEI: 549300ITOVH0OY7PZC34 | Long             | EC               |  | US        |    168741 | NS      | $2441682.27   | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Align Technology Inc                                       | Align Technology Inc                                        | CUSIP: 016255101<br>LEI: 549300N5YSE0U3LCP840 | Long             | EC               | CORP              | US        |     10374 | NS      | $2187876.60   | 0.44%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | BIOGEN INC                                                  | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -11 | NC      | $-8030.00     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| GLAXOSMITHKLINE CAPITAL                                    | GlaxoSmithKline Capital PLC                                 | CUSIP: 377373AG0<br>LEI: 549300U0LV41VX7LEP38 | Long             | DBT              | CORP              | GB        |   1400000 | PA      | $1362405.28   | 0.28%             | 2024-06-01      | Fixed         | 3.00%                 | No            |                  2 | On Loan: No      |
| IQVIA Holdings Inc                                         | IQVIA Holdings Inc                                          | CUSIP: 46266C105<br>LEI: 549300W3R20NM4KQPH86 | Long             | EC               | CORP              | US        |     12104 | NS      | $2479988.56   | 0.50%             |  |  |  | No            |                  1 | On Loan: No      |
| Goldman Sachs Bank USA                                     | PURCHASED USD / SOLD AUD                                    | CUSIP: 000000000<br>LEI: KD3XUN7C6T14HNAYLU02 | N/A              | DFE              |  | US        |         1 | NC      | $-21369.93    | -0.00%            |  |  |  | No            |                  2 | On Loan: No      |
| Moderna Inc                                                | Moderna Inc                                                 | CUSIP: 60770K107<br>LEI: 549300EI6OKH5K5Q2G38 | Long             | EC               | CORP              | US        |     14416 | NS      | $2589401.92   | 0.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Biohaven Ltd                                               | Biohaven Ltd                                                | CUSIP: 000000000<br>LEI: N/A                  | Long             | EC               | CORP              | VG        |     13100 | NS      | $181828.00    | 0.04%             |  |  |  | No            |                  1 | On Loan: —       |
| Stryker Corp                                               | Stryker Corp                                                | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |     40329 | NS      | $9860037.21   | 2.00%             |  |  |  | No            |                  1 | On Loan: No      |
| HCA Inc                                                    | HCA Inc                                                     | CUSIP: 404119BR9<br>LEI: L3CJ6J7LJ2DX62FTXD46 | Long             | DBT              | CORP              | US        |   1250000 | PA      | $1249433.14   | 0.25%             | 2025-02-01      | Fixed         | 5.38%                 | No            |                  2 | On Loan: No      |
| M3 Inc                                                     | M3 Inc                                                      | CUSIP: 000000000<br>LEI: 3538001UOKRWIODYM055 | Long             | EC               | CORP              | JP        |      7436 | NS      | $202727.89    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| ELEVANCE HEALTH INC                                        | Elevance Health Inc                                         | CUSIP: 036752AP8<br>LEI: 8MYN82XMYQH89CTMTH67 | Long             | DBT              | CORP              | US        |   3200000 | PA      | $2690550.53   | 0.55%             | 2031-03-15      | Fixed         | 2.55%                 | No            |                  2 | On Loan: No      |
| Merck & Co Inc                                             | Merck & Co Inc                                              | CUSIP: 58933YAR6<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | DBT              | CORP              | US        |   1463000 | PA      | $1403111.90   | 0.28%             | 2025-02-10      | Fixed         | 2.75%                 | No            |                  2 | On Loan: No      |
| Options Clearing Corp.                                     | HCA HEALTHCARE INC                                          | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -24 | NC      | $-4968.00     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Smith & Nephew PLC                                         | Smith & Nephew PLC                                          | CUSIP: 83175M205<br>LEI: 213800ZTMDN8S67S1H61 | Long             | EC               | CORP              | GB        |    181710 | NS      | $4886181.90   | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                                          | Johnson & Johnson                                           | CUSIP: 478160BY9<br>LEI: 549300G0CFPGEF6X2043 | Long             | DBT              | CORP              | US        |   4300000 | PA      | $4045116.86   | 0.82%             | 2026-03-01      | Fixed         | 2.45%                 | No            |                  2 | On Loan: No      |
| Diversified Healthcare Trust                               | Diversified Healthcare Trust                                | CUSIP: 25525P107<br>LEI: N/A                  | Long             | EC               |  | US        |     63841 | NS      | $41292.36     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                                           | Novo Nordisk A/S                                            | CUSIP: 670100205<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |    130523 | NS      | $17664982.82  | 3.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | UNITEDHEALTH GROUP INC                                      | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -63 | NC      | $-29862.00    | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                                            | AstraZeneca PLC                                             | CUSIP: 046353108<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |    242692 | NS      | $16454517.60  | 3.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Cigna Corp                                                 | Cigna Corp                                                  | CUSIP: 125523100<br>LEI: 549300VIWYMSIGT1U456 | Long             | EC               | CORP              | US        |     40328 | NS      | $13362279.52  | 2.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | ILLUMINA INC                                                | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -35 | NC      | $-2975.00     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Illumina Inc                                               | Illumina Inc                                                | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |     35804 | NS      | $7239568.80   | 1.47%             |  |  |  | No            |                  1 | On Loan: No      |
| LTC Properties Inc                                         | LTC Properties Inc                                          | CUSIP: 502175102<br>LEI: 549300NRZP8IJG2KY677 | Long             | EC               |  | US        |     46903 | NS      | $1666463.59   | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Astellas Pharma Inc                                        | Astellas Pharma Inc                                         | CUSIP: 000000000<br>LEI: 529900IB708DY2HBBB35 | Long             | EC               | CORP              | JP        |     44419 | NS      | $679112.49    | 0.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | ASTRAZENECA PLC                                             | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | GB        |      -469 | NC      | $-23450.00    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Eisai Co Ltd                                               | Eisai Co Ltd                                                | CUSIP: 000000000<br>LEI: 353800HDEE0ZYEX4QV91 | Long             | EC               | CORP              | JP        |      6830 | NS      | $452974.09    | 0.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | HCA HEALTHCARE INC                                          | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -21 | NC      | $-11151.00    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Goldman Sachs Bank USA                                     | PURCHASED USD / SOLD DKK                                    | CUSIP: 000000000<br>LEI: KD3XUN7C6T14HNAYLU02 | N/A              | DFE              |  | US        |         1 | NC      | $-26625.33    | -0.01%            |  |  |  | No            |                  2 | On Loan: No      |
| Options Clearing Corp.                                     | BIOGEN INC                                                  | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -11 | NC      | $-1925.00     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Guardant Health Inc                                        | Guardant Health Inc                                         | CUSIP: 40131M109<br>LEI: 254900M8C3E5VC8BR186 | Long             | EC               | CORP              | US        |     53333 | NS      | $1450657.60   | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Goldman Sachs Bank USA                                     | PURCHASED USD / SOLD ILS                                    | CUSIP: 000000000<br>LEI: KD3XUN7C6T14HNAYLU02 | N/A              | DFE              |  | US        |         1 | NC      | $2969.40      | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Mallinckrodt PLC                                           | Mallinckrodt PLC                                            | CUSIP: 000000000<br>LEI: 549300LMDE3RUP8Z3L60 | Long             | EC               | CORP              | IE        |     35048 | NS      | $271622.00    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                                             | Merck & Co Inc                                              | CUSIP: 58933YAF2<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | DBT              | CORP              | US        |   1400000 | PA      | $1389544.93   | 0.28%             | 2023-05-18      | Fixed         | 2.80%                 | No            |                  2 | On Loan: No      |
| SYNEOS HEALTH INC                                          | Syneos Health Inc                                           | CUSIP: 87166BAA0<br>LEI: 549300F1ZGKDS8P6GU13 | Long             | DBT              | CORP              | US        |   2300000 | PA      | $1850350.00   | 0.38%             | 2029-01-15      | Fixed         | 3.63%                 | No            |                  2 | On Loan: No      |
| Goldman Sachs Bank USA                                     | PURCHASED USD / SOLD JPY                                    | CUSIP: 000000000<br>LEI: KD3XUN7C6T14HNAYLU02 | N/A              | DFE              |  | US        |         1 | NC      | $-43596.59    | -0.01%            |  |  |  | No            |                  2 | On Loan: No      |
| Options Clearing Corp.                                     | STRYKER CORP                                                | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -44 | NC      | $-35200.00    | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| Perrigo Co PLC                                             | Perrigo Co PLC                                              | CUSIP: 000000000<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |     15882 | NS      | $541417.38    | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | BRISTOL-MYERS SQUIBB CO                                     | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |      -216 | NC      | $-216.00      | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Sabra Health Care REIT Inc                                 | Sabra Health Care REIT Inc                                  | CUSIP: 78573L106<br>LEI: 549300E3BC7GU7TAZ621 | Long             | EC               |  | US        |     90781 | NS      | $1128407.83   | 0.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | DEXCOM INC                                                  | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |      -103 | NC      | $-10300.00    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG                                           | Roche Holding AG                                            | CUSIP: 771195104<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |    603430 | NS      | $23624284.50  | 4.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | MOLINA HEALTHCARE INC                                       | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -18 | NC      | $-14400.00    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | MEDTRONIC PLC                                               | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | IE        |      -101 | NC      | $-19190.00    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Community Healthcare Trust Inc                             | Community Healthcare Trust Inc                              | CUSIP: 20369C106<br>LEI: 549300FATSRCMKOV9536 | Long             | EC               |  | US        |     14900 | NS      | $533420.00    | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Intuitive Surgical Inc                                     | Intuitive Surgical Inc                                      | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |     29795 | NS      | $7906103.25   | 1.60%             |  |  |  | No            |                  1 | On Loan: No      |
| National Health Investors Inc                              | National Health Investors Inc                               | CUSIP: 63633D104<br>LEI: 549300ZPKZIG6DKDEC02 | Long             | EC               |  | US        |      4442 | NS      | $231961.24    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| ICON PLC                                                   | ICON PLC                                                    | CUSIP: 000000000<br>LEI: 6354008SRQGEMC4XFI67 | Long             | EC               | CORP              | IE        |      6534 | NS      | $1269229.50   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                                                  | Amgen Inc                                                   | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     28956 | NS      | $7605003.84   | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi                                                     | Sanofi                                                      | CUSIP: 80105N105<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |    123454 | NS      | $5978877.22   | 1.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | IDEXX LABORATORIES INC                                      | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |        -9 | NC      | $-4500.00     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| CIGNA CORP                                                 | Cigna Corp                                                  | CUSIP: 125523BX7<br>LEI: 549300VIWYMSIGT1U456 | Long             | DBT              | CORP              | US        |   2785000 | PA      | $2724301.15   | 0.55%             | 2024-06-15      | Fixed         | 3.50%                 | No            |                  2 | On Loan: No      |
| Goldman Sachs Bank USA                                     | PURCHASED USD / SOLD GBP                                    | CUSIP: 000000000<br>LEI: KD3XUN7C6T14HNAYLU02 | N/A              | DFE              |  | US        |         1 | NC      | $9388.08      | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| ENDEAVOR BIOMEDICINES, INC.                                | ENDEAVOR BIOMEDICINES, INC.                                 | CUSIP: 000000000<br>LEI: N/A                  | Long             | EP               | CORP              | US        |    424079 | NS      | $1999998.97   | 0.41%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Options Clearing Corp.                                     | HUMANA INC                                                  | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -10 | NC      | $-630.00      | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                                                 | Pfizer Inc                                                  | CUSIP: 717081ET6<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | DBT              | CORP              | US        |   5300000 | PA      | $4994091.47   | 1.01%             | 2029-03-15      | Fixed         | 3.45%                 | No            |                  2 | On Loan: No      |
| ENDO DAC/FIN LLC/FINCO                                     | Endo Dac / Endo Finance LLC / Endo Finco Inc                | CUSIP: 29273DAB6<br>LEI: N/A                  | Long             | DBT              | CORP              | XX        |    516000 | PA      | $72240.00     | 0.01%             | 2027-07-31      | None          | 0.00%                 | No            |                  2 | On Loan: No      |
| Novartis Capital Corp                                      | Novartis Capital Corp                                       | CUSIP: 66989HAG3<br>LEI: 5493002KF87V5RSRQS84 | Long             | DBT              | CORP              | US        |   2115000 | PA      | $2072758.10   | 0.42%             | 2024-05-06      | Fixed         | 3.40%                 | No            |                  2 | On Loan: No      |
| Ono Pharmaceutical Co Ltd                                  | Ono Pharmaceutical Co Ltd                                   | CUSIP: 000000000<br>LEI: 529900G26L4NG4GFJZ86 | Long             | EC               | CORP              | JP        |     11330 | NS      | $266156.58    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                                        | Abbott Laboratories                                         | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |    183665 | NS      | $20164580.35  | 4.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | ABBOTT LABORATORIES                                         | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |      -305 | NC      | $-70150.00    | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | DEXCOM INC                                                  | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -68 | NC      | $-23392.00    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Lonza Group AG                                             | Lonza Group AG                                              | CUSIP: 000000000<br>LEI: 549300EFW4H2TCZ71055 | Long             | EC               | CORP              | CH        |      9053 | NS      | $4436180.50   | 0.90%             |  |  |  | No            |                  1 | On Loan: No      |
| OCULIS SA SERIES C                                         | OCULIS SA SERIES C                                          | CUSIP: 000000000<br>LEI: N/A                  | Long             | EP               | CORP              | US        |     41109 | NS      | $437399.76    | 0.09%             |  |  |  | Yes           |                  3 | On Loan: No      |
| CSL Ltd                                                    | CSL Ltd                                                     | CUSIP: 000000000<br>LEI: 529900ECSECK5ZDQTE14 | Long             | EC               | CORP              | AU        |     38719 | NS      | $7585882.05   | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Dexcom Inc                                                 | Dexcom Inc                                                  | CUSIP: 252131107<br>LEI: 549300YSK3QDSFR5EU59 | Long             | EC               | CORP              | US        |     71367 | NS      | $8081599.08   | 1.64%             |  |  |  | No            |                  1 | On Loan: No      |
| ENDO DAC/FIN LLC/FINCO                                     | Endo Dac / Endo Finance LLC / Endo Finco Inc                | CUSIP: 29273DAC4<br>LEI: N/A                  | Long             | DBT              | CORP              | XX        |    789000 | PA      | $41422.50     | 0.01%             | 2028-06-30      | None          | 0.00%                 | No            |                  2 | On Loan: No      |
| Johnson & Johnson                                          | Johnson & Johnson                                           | CUSIP: 478160CK8<br>LEI: 549300G0CFPGEF6X2043 | Long             | DBT              | CORP              | US        |   1400000 | PA      | $1306742.35   | 0.27%             | 2028-01-15      | Fixed         | 2.90%                 | No            |                  2 | On Loan: No      |
| Pfizer Inc                                                 | Pfizer Inc                                                  | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |    403610 | NS      | $20680976.40  | 4.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Hoya Corp                                                  | Hoya Corp                                                   | CUSIP: 000000000<br>LEI: 353800X4VR3BHEUCJB42 | Long             | EC               | CORP              | JP        |      9682 | NS      | $937289.01    | 0.19%             |  |  |  | No            |                  1 | On Loan: No      |
| Ardelyx Inc                                                | Ardelyx Inc                                                 | CUSIP: 039697107<br>LEI: 549300F542QR4SXHCY32 | Long             | EC               | CORP              | US        |    282002 | NS      | $803705.70    | 0.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Baxalta Inc                                                | Baxalta Inc                                                 | CUSIP: 07177MAB9<br>LEI: 5493000JW8DCO3T45R55 | Long             | DBT              | CORP              | US        |    831000 | PA      | $809467.14    | 0.16%             | 2025-06-23      | Fixed         | 4.00%                 | No            |                  2 | On Loan: No      |
| Molina Healthcare Inc                                      | Molina Healthcare Inc                                       | CUSIP: 60855R100<br>LEI: 549300NQQCEQ46YHZ591 | Long             | EC               | CORP              | US        |     18716 | NS      | $6180397.52   | 1.25%             |  |  |  | No            |                  1 | On Loan: No      |
| UNITEDHEALTH GROUP INC                                     | UnitedHealth Group Inc                                      | CUSIP: 91324PEJ7<br>LEI: 549300GHBMY8T5GXDE41 | Long             | DBT              | CORP              | US        |   6060000 | PA      | $5769148.60   | 1.17%             | 2032-05-15      | Fixed         | 4.20%                 | No            |                  2 | On Loan: No      |
| Medtronic Inc                                              | Medtronic Inc                                               | CUSIP: 585055BT2<br>LEI: D56MRZY2INAN94ZONZ37 | Long             | DBT              | CORP              | US        |   1675000 | PA      | $1589269.03   | 0.32%             | 2035-03-15      | Fixed         | 4.38%                 | No            |                  2 | On Loan: No      |
| Edwards Lifesciences Corp                                  | Edwards Lifesciences Corp                                   | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |     33603 | NS      | $2507119.83   | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                                                  | Argenx SE                                                   | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |      8220 | NS      | $3113982.60   | 0.63%             |  |  |  | No            |                  1 | On Loan: No      |
| BRISTOL-MYERS SQUIBB CO                                    | Bristol-Myers Squibb Co                                     | CUSIP: 110122CP1<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | DBT              | CORP              | US        |   1400000 | PA      | $1301045.83   | 0.26%             | 2029-07-26      | Fixed         | 3.40%                 | No            |                  2 | On Loan: No      |
| 1Life Healthcare Inc                                       | 1Life Healthcare Inc                                        | CUSIP: 68269G107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     10451 | NS      | $174636.21    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                                        | Abbott Laboratories                                         | CUSIP: 002824BG4<br>LEI: HQD377W2YR662HK5JX27 | Long             | DBT              | CORP              | US        |   5652000 | PA      | $5624316.56   | 1.14%             | 2036-11-30      | Fixed         | 4.75%                 | No            |                  2 | On Loan: No      |
| AlerisLife Inc                                             | AlerisLife Inc                                              | CUSIP: 33832D205<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4325 | NS      | $2378.75      | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Allscripts Healthcare Solutions Inc                        | Allscripts Healthcare Solutions Inc                         | CUSIP: 01988P108<br>LEI: Y68YJHVB1GU4TAU3C223 | Long             | EC               | CORP              | US        |     90363 | NS      | $1594003.32   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| EMD Finance LLC                                            | EMD Finance LLC                                             | CUSIP: 26867LAL4<br>LEI: 529900C8KS5G529A0B76 | Long             | DBT              | CORP              | US        |   4000000 | PA      | $3835987.92   | 0.78%             | 2025-03-19      | Fixed         | 3.25%                 | No            |                  2 | On Loan: No      |
| DYNACURE                                                   | DYNACURE                                                    | CUSIP: 000000000<br>LEI: N/A                  | Long             | EP               | CORP              | FR        |    337442 | NS      | $1049328.46   | 0.21%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Options Clearing Corp.                                     | ACADIA HEALTHCARE CO INC                                    | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -35 | NC      | $-15050.00    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Goldman Sachs Bank USA                                     | PURCHASED USD / SOLD EUR                                    | CUSIP: 000000000<br>LEI: KD3XUN7C6T14HNAYLU02 | N/A              | DFE              |  | US        |         1 | NC      | $-46144.34    | -0.01%            |  |  |  | No            |                  2 | On Loan: No      |
| Bayer AG                                                   | Bayer AG                                                    | CUSIP: 000000000<br>LEI: 549300J4U55H3WP1XT59 | Long             | EC               | CORP              | DE        |    131684 | NS      | $6811943.75   | 1.38%             |  |  |  | No            |                  1 | On Loan: No      |
| Fusion Pharmaceuticals Inc                                 | Fusion Pharmaceuticals Inc                                  | CUSIP: 36118A100<br>LEI: N/A                  | Long             | EC               | CORP              | CA        |      7378 | NS      | $23240.70     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | ELI LILLY + CO                                              | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -68 | NC      | $-41820.00    | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| I-Mab                                                      | I-Mab                                                       | CUSIP: 44975P103<br>LEI: 549300L1A5T19703RR64 | Long             | EC               | CORP              | KY        |     38848 | NS      | $162384.64    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Acadia Healthcare Co Inc                                   | Acadia Healthcare Co Inc                                    | CUSIP: 00404A109<br>LEI: 5493005CW985Y9D0NC11 | Long             | EC               | CORP              | US        |     35969 | NS      | $2960968.08   | 0.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Laboratory Corp of America Holdings                        | Laboratory Corp of America Holdings                         | CUSIP: 50540R409<br>LEI: OZ7UA8IXAIFILY2VZH07 | Long             | EC               | CORP              | US        |      8389 | NS      | $1975441.72   | 0.40%             |  |  |  | No            |                  1 | On Loan: No      |
| BeiGene Ltd                                                | BeiGene Ltd                                                 | CUSIP: 07725L102<br>LEI: 549300JFUK6FRD5MH739 | Long             | EC               | CORP              | KY        |      4114 | NS      | $904833.16    | 0.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Sysmex Corp                                                | Sysmex Corp                                                 | CUSIP: 000000000<br>LEI: 5299001ZO4CKWACMZI55 | Long             | EC               | CORP              | JP        |      3715 | NS      | $226398.74    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| MorphoSys AG                                               | MorphoSys AG                                                | CUSIP: 617760202<br>LEI: 529900493806K77LRE72 | Long             | EC               | CORP              | DE        |     81867 | NS      | $293083.86    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| Affimed NV                                                 | Affimed NV                                                  | CUSIP: 000000000<br>LEI: 5493004V4FSXT1D04610 | Long             | EC               | CORP              | NL        |     10000 | NS      | $12400.00     | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | CIGNA CORP                                                  | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -39 | NC      | $-14625.00    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| GLAXOSMITHKLINE CAPITAL                                    | GlaxoSmithKline Capital PLC                                 | CUSIP: 377373AH8<br>LEI: 549300U0LV41VX7LEP38 | Long             | DBT              | CORP              | GB        |   1000000 | PA      | $924031.84    | 0.19%             | 2029-06-01      | Fixed         | 3.38%                 | No            |                  2 | On Loan: No      |
| HealthEquity Inc                                           | HealthEquity Inc                                            | CUSIP: 42226A107<br>LEI: 529900LRJU1RAFQHM467 | Long             | EC               | CORP              | US        |     12000 | NS      | $739680.00    | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| HCA Healthcare Inc                                         | HCA Healthcare Inc                                          | CUSIP: 40412C101<br>LEI: 529900PH4ZGUH2MNEU89 | Long             | EC               | CORP              | US        |     22603 | NS      | $5423815.88   | 1.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Terumo Corp                                                | Terumo Corp                                                 | CUSIP: 000000000<br>LEI: 353800JX1R4582QVK932 | Long             | EC               | CORP              | JP        |     17288 | NS      | $493453.58    | 0.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Avantor Inc                                                | Avantor Inc                                                 | CUSIP: 05352A100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    142388 | NS      | $3002962.92   | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Takeda Pharmaceutical Co Ltd                               | Takeda Pharmaceutical Co Ltd                                | CUSIP: 000000000<br>LEI: 549300ZLMVP4X0OGR454 | Long             | EC               | CORP              | JP        |      9600 | NS      | $300713.20    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| McKesson Corp                                              | McKesson Corp                                               | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |     11501 | NS      | $4314255.12   | 0.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Humana Inc                                                 | Humana Inc                                                  | CUSIP: 444859102<br>LEI: 529900YLDW34GJAO4J06 | Long             | EC               | CORP              | US        |     21683 | NS      | $11105815.77  | 2.25%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | VERTEX PHARMACEUTICALS INC                                  | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -15 | NC      | $-6750.00     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | ARGENX SE                                                   | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | NL        |       -12 | NC      | $-3540.00     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| PRIOTHERA LIMITED                                          | PRIOTHERA LIMITED                                           | CUSIP: 000000000<br>LEI: N/A                  | Long             | EP               | CORP              | IE        |    194134 | NS      | $2078106.42   | 0.42%             |  |  |  | Yes           |                  3 | On Loan: No      |
| Danaher Corp                                               | Danaher Corp                                                | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |     30958 | NS      | $8216872.36   | 1.67%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc                              | Regeneron Pharmaceuticals Inc                               | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |      4199 | NS      | $3029536.51   | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| State Street Institutional US Government Money Market Fund | State Street Institutional US Government Money Market Fund  | CUSIP: 857492573<br>LEI: N/A                  | Long             | STIV             | RF                | US        |    182280 | NS      | $182280.00    | 0.04%             |  |  |  | No            |                  1 | On Loan: No      |
| Medical Properties Trust Inc                               | Medical Properties Trust Inc                                | CUSIP: 58463J304<br>LEI: 254900U6E39J1MQCCY14 | Long             | EC               |  | US        |    145186 | NS      | $1617372.04   | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Shionogi & Co Ltd                                          | Shionogi & Co Ltd                                           | CUSIP: 000000000<br>LEI: 35380049VXDTHZI3DY35 | Long             | EC               | CORP              | JP        |      7707 | NS      | $386759.39    | 0.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | PFIZER INC                                                  | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |      -577 | NC      | $-35774.00    | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| Stevanato Group SpA                                        | Stevanato Group SpA                                         | CUSIP: 000000000<br>LEI: 81560033F7E1CD477507 | Long             | EC               | CORP              | IT        |     71190 | NS      | $1279284.30   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| SHIRE ACQ INV IRELAND DA                                   | Shire Acquisitions Investments Ireland DAC                  | CUSIP: 82481LAD1<br>LEI: 549300XK5HGW68R8K327 | Long             | DBT              | CORP              | IE        |   1500000 | PA      | $1408966.53   | 0.29%             | 2026-09-23      | Fixed         | 3.20%                 | No            |                  2 | On Loan: No      |
| Community Health Systems Inc                               | Community Health Systems Inc                                | CUSIP: 203668108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8700 | NS      | $37584.00     | 0.01%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                                     | UnitedHealth Group Inc                                      | CUSIP: 91324PDP4<br>LEI: 549300GHBMY8T5GXDE41 | Long             | DBT              | CORP              | US        |   2560000 | PA      | $2446272.08   | 0.50%             | 2028-12-15      | Fixed         | 3.88%                 | No            |                  2 | On Loan: No      |
| Teva Pharmaceutical Industries Ltd                         | Teva Pharmaceutical Industries Ltd                          | CUSIP: 881624209<br>LEI: 549300BAFGM4RC74ZJ94 | Long             | EC               | CORP              | IL        |     90281 | NS      | $823362.72    | 0.17%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | BOSTON SCIENTIFIC CORP                                      | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -98 | NC      | $-7350.00     | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Novartis AG                                                | Novartis AG                                                 | CUSIP: 66987V109<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |    136225 | NS      | $12358332.00  | 2.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Healthcare Realty Trust Inc                                | Healthcare Realty Trust Inc                                 | CUSIP: 42226K105<br>LEI: 549300L0I14L7I0VLX84 | Long             | EC               |  | US        |    149567 | NS      | $2882156.09   | 0.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                                             | Merck & Co Inc                                              | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    149510 | NS      | $16588134.50  | 3.36%             |  |  |  | No            |                  1 | On Loan: No      |
| Healthpeak Properties Inc                                  | Healthpeak Properties Inc                                   | CUSIP: 42250P103<br>LEI: PZ9HF5U52KPF0MH0QN75 | Long             | EC               |  | US        |     83601 | NS      | $2095877.07   | 0.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                                             | Eli Lilly & Co                                              | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |     69036 | NS      | $25256130.24  | 5.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Galera Therapeutics Inc                                    | Galera Therapeutics Inc                                     | CUSIP: 36338D108<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    161709 | NS      | $240946.41    | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| CIGNA CORP                                                 | Cigna Corp                                                  | CUSIP: 125523CM0<br>LEI: 549300VIWYMSIGT1U456 | Long             | DBT              | CORP              | US        |   3200000 | PA      | $2627270.53   | 0.53%             | 2031-03-15      | Fixed         | 2.38%                 | No            |                  2 | On Loan: No      |
| Catalent Inc                                               | Catalent Inc                                                | CUSIP: 148806102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     36156 | NS      | $1627381.56   | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Becton Dickinson and Co                                    | Becton Dickinson and Co                                     | CUSIP: 075887BF5<br>LEI: ICE2EP6D98PQUILVRZ91 | Long             | DBT              | CORP              | US        |    328000 | PA      | $319768.90    | 0.06%             | 2024-12-15      | Fixed         | 3.73%                 | No            |                  2 | On Loan: No      |
| Options Clearing Corp.                                     | NOVO NORDISK A/S                                            | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | DK        |      -192 | NC      | $-65856.00    | -0.01%            |  |  |  | No            |                  1 | On Loan: No      |
| IDEXX Laboratories Inc                                     | IDEXX Laboratories Inc                                      | CUSIP: 45168D104<br>LEI: OGMTXK0LUU1HKV2P0J84 | Long             | EC               | CORP              | US        |     19168 | NS      | $7819777.28   | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Options Clearing Corp.                                     | ELI LILLY + CO                                              | CUSIP: 000000000<br>LEI: 549300CII6SLYGKNHA04 | N/A              | DE               |  | US        |       -67 | NC      | $-11055.00    | -0.00%            |  |  |  | No            |                  1 | On Loan: No      |
| Par Pharmaceutical Inc                                     | Par Pharmaceutical Inc                                      | CUSIP: 69888XAA7<br>LEI: 549300KK5WR4MGN4YT97 | Long             | DBT              | CORP              | US        |    193000 | PA      | $146675.11    | 0.03%             | 2027-04-01      | None          | 0.00%                 | No            |                  2 | On Loan: No      |
| Bristol-Myers Squibb Co                                    | Bristol-Myers Squibb Co                                     | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    147326 | NS      | $10600105.70  | 2.15%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                                        | Gilead Sciences Inc                                         | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |     63888 | NS      | $5484784.80   | 1.11%             |  |  |  | No            |                  1 | On Loan: No      |
| MALLINCKRODT FIN/SB                                        | Mallinckrodt International Finance SA / Mallinckrodt CB LLC | CUSIP: 561233AK3<br>LEI: N/A                  | Long             | DBT              | CORP              | LU        |    997000 | PA      | $535877.53    | 0.11%             | 2029-06-15      | Fixed         | 10.00%                | No            |                  2 | On Loan: No      |
| Koninklijke Philips NV                                     | Koninklijke Philips NV                                      | CUSIP: 500472303<br>LEI: H1FJE8H61JGM1JSGM897 | Long             | EC               | CORP              | NL        |    109860 | NS      | $1646801.40   | 0.33%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-01-24

**Name of Applicant:** Tekla World Healthcare Fund

**Signature:** Laura Woodward

**Name of Signer:** Laura Woodward

**Title:** CCO